dostęp otwarty
Czy terapia Recover skutecznie zmniejsza ból u kobiet z wulwodynią?
, 2, 1, , 1, 1, 1
Afiliacje- Terpa, Pogodna 34, 20-333 Lublin, Polska
- III Katedra i Klinika Ginekologii Uniwersytetu Medycznego w Lublinie
dostęp otwarty
Streszczenie
Streszczenie
Słowa kluczowe
ból narządów płciowych i miednicy/ból penetracyjny, dysfunkcja mięśni dna miednicy, dyspareunia, przewlekły ból, terapia multidyscyplinarna, wulwodynia
Informacje o artykuleTytuł
Czy terapia Recover skutecznie zmniejsza ból u kobiet z wulwodynią?
Czasopismo
Journal of Sexual and Mental Health
Numer
Tom 18 (2020): Continuous Publishing
Typ artykułu
Praca badawcza (oryginalna)
Opublikowany online
2020-12-01
Wyświetlenia strony
1097
Wyświetlenia/pobrania artykułu
536
DOI
Rekord bibliograficzny
Seksuologia Polska 2020;18.
Słowa kluczowe
ból narządów płciowych i miednicy/ból penetracyjny
dysfunkcja mięśni dna miednicy
dyspareunia
przewlekły ból
terapia multidyscyplinarna
wulwodynia
Autorzy
Ewa Baszak-Radomańska
Jadwiga Wańczyk-Baszak
Marta Nowosad
Joanna Sawka
Agnieszka Mazurkiewicz
Karolina Ochnik-Bąk
Paweł Malicki
Referencje (26)- Bornstein J, Goldstein AT, Stockdale CK, et al. consensus vulvar pain terminology committee of the International Society for the Study of Vulvovaginal Disease (ISSVD), the International Society for the Study of Womenʼs Sexual Health (ISSWSH), and the International Pelvic Pain Society (IPPS). 2015 ISSVD, ISSWSH, and IPPS Consensus Terminology and Classification of Persistent Vulvar Pain and Vulvodynia. J Low Genit Tract Dis. 2016; 20(2): 126–130.
- Jantos MA. Myofascial perspective on chronic urogenital pain in women. In: Santoro GA, Wieczorek AP, Bartram C. ed. Pelvic floor disorders . Springer 2021.
- Reissing ED, Brown C, Lord MJ, et al. Pelvic floor muscle functioning in women with vulvar vestibulitis syndrome. J Psychosom Obstet Gynaecol. 2005; 26: 107–113.
- Bo K, Frawley HC, Haylen BT, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Neurourol Urodyn. 2017; 36(2): 221–244.
- Hartmann D, Sarton J. Chronic pelvic floor dysfunction. Best Pract Res Clin Obstet Gynaecol. 2014; 28(7): 977–990.
- Bergeron S, Reed BD, Wesselmann U, et al. Vulvodynia. Nat Rev Dis Primers. 2020; 6(36): 1–20.
- Faubion SS, Shuster LT, Bharucha AE. Recognition and management of nonrelaxing pelvic floor dysfunction. Mayo Clin Proc. 2012; 87(2): 187–193.
- Goldstein AT. Pain, and pelvic pain. In: Goldstein AT, Pukall CF. ed. Female sexual pain disorders: evaluation and management. John Wiley & Sons Ltd. 2020.
- Lee N, Jakes A, Lloyd J, et al. Dyspareunia. BMJ. 2018: k2341.
- Goldstein AT, Pukall CF, Brown C, et al. Vulvodynia: assessment and treatment. J Sex Med. 2016; 13(4): 572–590.
- Rosen NO, Dawson SJ, Brooks M, et al. Treatment of vulvodynia: pharmacological and non-pharmacological approaches. Drugs. 2019; 79(5): 483–493.
- Sorensen J, Bautista KE, Lamvu G, et al. Evaluation and treatment of female sexual pain: a clinical review. Cureus. 2018; 10(3): e2379.
- Goldfinger C, Pukall CF, Thibault-Gagnon S, et al. Effectiveness of Cognitive-Behavioral Therapy and Physical Therapy for Provoked Vestibulodynia: A Randomized Pilot Study. J Sex Med. 2016; 13(1): 88–94.
- Lewis GN, Bean D, Mowat R. How Have Chronic Pain Management Programs Progressed? A Mapping Review. Pain Pract. 2019; 19(7): 767–784.
- ACPA Resource Guide to Pain Medication and Treatment. https://www.theacpa.org/pain-management-tools/resource-ghttps://www.theacpa.org/wp-content/uploads/2019/02/ACPA_Resource_Guide_2019.pdfuide-to-chronic-pain-treatments/.
- Baszak-Radomańska E, Wańczyk-Baszak J. Farmakoterapia zaburzeń seksualnych związanych z bólem. In: Depko A, Mamcarz A. ed. Farmakoterapia zaburzeń seksualnych. PZWL w druku.
- Sadownik LA, Yong PJ, Smith KB. Systematic Review of Treatment Outcome Measures for Vulvodynia. J Low Genit Tract Dis. 2018; 22(3): 251–259.
- Pukall CF, Bergeron S, Brown C, et al. Vulvodynia Collaborative Research Group. Recommendations for Self-Report Outcome Measures in Vulvodynia Clinical Trials. Clin J Pain. 2017; 33(8): 756–765.
- Corsini-Munt S, Rancourt KM, Dubé JP, et al. Vulvodynia: a consideration of clinical and methodological research challenges and recommended solutions. J Pain Res. 2017; 10: 2425–2436.
- Baszak-Radomańska E, Wańczyk-Baszak J, Paszkowski T. Pilot study of testing a clinical tool for pelvic physical examination in patients with vulvodynia. Ginekol Pol. w druku.
- Pereira G, Soriano Marcolino M, Silveira Nogueira Reis Z, et al. A systematic review of drug treatment of vulvodynia: evidence of a strong placebo effect. BJOG. 2018; 125(10): 1216–1224.
- Davenport RB, Voutier CR, Veysey EC. Outcome Measurement Instruments for Provoked Vulvodynia: A Systematic Review. J Low Genit Tract Dis. 2018; 22(4): 396–404.
- Brotto LA, Yong P, Smith KB, et al. Impact of a multidisciplinary vulvodynia program on sexual functioning and dyspareunia. J Sex Med. 2015; 12(1): 238–247.
- Potente C, Giraudo D, Palleshi G, et al. Evaluation of the effectiveness of rehabilitation treatment in patients with chronic pelvic pain: a systematic review. Pelviperineology. 2019; 38(3): 70–77.
- Lev-Sagie A, Kopitman A, Brzezinski A. Low-Level Laser Therapy for the Treatment of Provoked Vestibulodynia — A Randomized, Placebo-Controlled Pilot Trial. J Sex Med. 2017; 14(11): 1403–1411.
- Reed BD, Harlow SD, Plegue MA, et al. Remission, Relapse, and Persistence of Vulvodynia: A Longitudinal Population-Based Study. J Womens Health (Larchmt). 2016; 25(3): 276–283.
